These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6261915)

  • 21. [Bone-seeking radiopharmaceuticals in evaluating the treatment of skeletal metastases of malignant tumors].
    Naumenko AZ; Korsunskiĭ VN
    Med Radiol (Mosk); 1984 Mar; 29(3):27-30. PubMed ID: 6321881
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The diagnosis of thyroid disease on bone scans.
    Peterdy AE
    Clin Nucl Med; 1985 Mar; 10(3):177-9. PubMed ID: 2985321
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comprehensive diagnostic approaches in tumor metastases in the skeleton. Results of radionuclide examination].
    Bek V; Kolár J; Janko L; Hausner P; Konopásek B; Nový F; Vosecký M; Stĕpán J
    Cas Lek Cesk; 1986 May; 125(22):677-83. PubMed ID: 3011270
    [No Abstract]   [Full Text] [Related]  

  • 24. [Electroroentgen scanning in the diagnosis of bone metastases].
    Survila PZ; Valutskas KK; Kaĭriukshtite IS
    Med Radiol (Mosk); 1984 Jul; 29(7):11-4. PubMed ID: 6087077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Bone scintigraphy in the preoperative determination of the stage of breast cancer].
    Denisov LE; Iarygin LM; Ermolaeva EV; Zhuravleva LI
    Med Radiol (Mosk); 1984 Jul; 29(7):5-8. PubMed ID: 6087080
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nuclear bone imaging in metastatic cancer of the prostate.
    Pollen JJ; Gerber K; Ashburn WL; Schmidt JD
    Cancer; 1981 Jun; 47(11):2585-94. PubMed ID: 6266636
    [No Abstract]   [Full Text] [Related]  

  • 27. 99mTc-antigranulocyte bone marrow scintigraphy of breast and prostate skeletal metastases.
    Limouris GS; Voliotopoulos V; Stavraka A; Vlahos L
    Anticancer Res; 1997; 17(3B):1615-8. PubMed ID: 9179204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The application of the 99Tcm phosphate bone scan to the study of breast cancer.
    Citrin DL; Bessent RG; Greig WR; McKellar NJ; Furnival C; Blumgart LH
    Br J Surg; 1975 Mar; 62(3):201-4. PubMed ID: 1122358
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radionuclide evaluation of skeletal metastases: practical considerations.
    Gold RH; Bassett LW
    Skeletal Radiol; 1986; 15(1):1-9. PubMed ID: 3941915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radionuclide bone scanning of osteosarcoma: falsely extended uptake patterns.
    Chew FS; Hudson TM
    AJR Am J Roentgenol; 1982 Jul; 139(1):49-54. PubMed ID: 6283871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experience with 7,604 bone scintigraphies at time of operation for breast cancer 1977-1987.
    Thomsen HS; Lund JO; Munck O; Andersen KW
    Dan Med Bull; 1989 Oct; 36(5):481-3. PubMed ID: 2553340
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between number and sites of new bone scan abnormalities and presence of skeletal metastases in patients with breast cancer.
    Jacobson AF; Stomper PC; Jochelson MS; Ascoli DM; Henderson IC; Kaplan WD
    J Nucl Med; 1990 Apr; 31(4):387-92. PubMed ID: 2324816
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Bone scintigraphy with 99mTc-pyrophosphate in the diagnosis of the degree of the spread of the tumor process in the head and neck area].
    Prikhod'ko AG
    Med Radiol (Mosk); 1982 Jan; 27(1):58-67. PubMed ID: 6276643
    [No Abstract]   [Full Text] [Related]  

  • 34. Radionuclide liver and bone scanning in the evaluation of patients with endometrial carcinoma.
    Mettler FA; Christie JH; Garcia JF; Baldwin MH; Wicks JD; Bartow SA
    Radiology; 1981 Dec; 141(3):777-80. PubMed ID: 6272356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Staging of renal cell carcinoma: cost-effectiveness of routine preoperative bone scans.
    Campbell RJ; Broaddus SB; Leadbetter GW
    Urology; 1985 Mar; 25(3):326-9. PubMed ID: 2983477
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Breast cancer with bone-only metastases. Visceral metastases-free rate in relation to anatomic distribution of bone metastases.
    Yamashita K; Ueda T; Komatsubara Y; Koyama H; Inaji H; Yonenobu K; Ono K
    Cancer; 1991 Aug; 68(3):634-7. PubMed ID: 2065284
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic activity in bone metastases of breast and prostate cancer were similar as studied by
    Pietrzak A; Czepczynski R; Wierzchoslawska E; Cholewinski W
    Hell J Nucl Med; 2017; 20(3):237-240. PubMed ID: 29177262
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictive value of bone scans in an adjuvant breast cancer program.
    Hammond N; Jones SE; Salmon SE; Patton D; Woolfenden J
    Cancer; 1978 Jan; 41(1):138-42. PubMed ID: 626924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparing whole body 18F-2-deoxyglucose positron emission tomography and technetium-99m methylene diophosphate bone scan to detect bone metastases in patients with non-small cell lung cancer.
    Hsia TC; Shen YY; Yen RF; Kao CH; Changlai SP
    Neoplasma; 2002; 49(4):267-71. PubMed ID: 12382027
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors of a positive baseline bone scan in breast cancer.
    Ho YY; Chan YH
    Australas Radiol; 2005 Feb; 49(1):21-6. PubMed ID: 15727605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.